XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
10. Segment Information Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Information regarding operating segments for the three months ended September 30, 2022 and 2021 is as follows (in millions):

Life
Science
Clinical
Diagnostics
Other
Operations
Segment net sales 2022$317.9 $361.9 $1.0 
 2021$373.5 $372.2 $1.3 
Segment net profit (loss)2022$45.7 $36.0 $(0.6)
 2021$105.8 $50.7 $(0.2)
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
The following reconciles total segment profit to consolidated income (loss) before income taxes (in millions):

Three Months EndedNine Months Ended
September 30,September 30,
 2022202120222021
Total segment profit $81.1 $156.3 $330.0 $381.2 
Foreign currency exchange gains (losses), net(4.4)(2.2)(3.1)(0.5)
Gains (losses) from change in fair market value of equity securities and loan receivable(289.0)4,868.7 (6,172.3)7,078.8 
Other income (expense), net3.1 (0.6)42.3 16.7 
Consolidated income (loss) before income taxes$(209.2)$5,022.2 $(5,803.1)$7,476.2